Navigation Links
BioNeutral Chief Scientist Dr. Andy Kielbania Appointed to Steri - 7 for Expanded Role

Reza Hygiene, a member of the Alireza Group of Companies, Appointed by Steri - 7 as Exclusive Distributor/Manufacturer for Saudi Arabia and the Middle East

Newark, NJ (PRWEB) June 21, 2010 -- BioNeutral Group Inc (OTCBB : BONU), a specialty chemical technology-based life science company, announced today that its Chief Scientist, Dr. Andy Kielbania, will assist with a similar role in Steri – 7, upon the completion of the proposed acquisition by BioNeutral as the companies plan to integrate product lines to provide the best cleaner/disinfectants for the health care, industrial, military, consumer and institutional markets.

Dr. Kielbania said, "The two companies have complementary technology platforms which use different active ingredients. There will be markets where regulators/distributors prefer one or the other. Our goal is to have the best formulation for our distributors and end users. I look forward to working with Jim and his entire team".

"It's a unique combination and opportunity to create a worldwide product offering with the best claims possible. Between compliance with the British regulatory system and the EPA the combined offering would cover every major market in the world", said James Fraser CEO of Steri – 7.

Also, Steri - 7, a UK based specialty chemical company in the health care field announced today the appointment of Reza Hygiene as its exclusive distributor/manufacturer for Saudi Arabia and the Middle East. Reza Hygiene ( is a division of the large and diverse Alireza Group of Companies (, owned by one of the most respected trading families in Saudi Arabia.

Keith Watson, Division Manager of Reza Hygiene said, "We are extremely interested in the Healthcare disinfectant/sterilization sector and of all the chemical technologies presented to us, we have chosen to partner with Steri - 7 as the performance of their proprietary formulations is second to none. We will be very active in promoting this new technology throughout the region".

James Fraser, CEO of Steri - 7 said, "Reza Hygiene is the perfect partner for Steri - 7. Our sporicidal formulations are the best in the field of disinfectants. The Alireza Group of Companies represent some of the best brands in the world and have the knowledge and the resources to present Steri - 7 as best of breed in the health care and related sectors".

In May, 2010, BioNeutral Group Inc. entered into a non-binding Head of Terms letter setting forth a plan to acquire all of the shares of Steri-7™. The acquisition is subject to negotiation of a definitive acquisition agreement, satisfactory completion of due diligence, completion of a specified financing transaction by BioNeutral, and other customary terms and conditions. Terms and conditions are being held confidential pending execution of a definitive agreement

About BioNeutral Group Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a specialty chemical technology-based life science company that is developing and intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous microorganisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), are both eco-friendly. The Company has combined widely used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene(TM) brand have not yet been submitted to the EPA for approval for sale in the United States; however they have been approved in Germany and are allowed in the UK, France and Sweden.
More information about the Company may be found at

About Steri-7(TM):
Steri-7(TM) is a privately held UK company with a broad product line of advanced proprietary antimicrobial formulations designed to eliminate bacteria, virus and spores in the health care and related industries with products which include sporicidal hard surface sprays, sporicidal wipes and sporicidal hand cleansers. All products are mild, environmentally friendly and provide long-lasting protection which is unique in the industry. Sales have commenced in the UK and the Middle East.
More information about Steri-7(TM) may be found

About Reza Group:
Reza Investment Company Ltd is wholly owned by the Alireza family, one of the oldest and most respected trading families in Saudi Arabia who have successfully developed market-leading positions in trading, manufacturing and service industries throughout Saudi Arabia
More information about The Reza Group can be found at

Forward-Looking Statements
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene™ and are not yet available for sale in the United States.

BioNeutral Group Inc.
Stephen J. Browand, President and CEO


Brian Becker, 201-341-2338
Investor Relations


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Steri -7 Appoints BioNeutral Group Inc. Chief Scientist Dr. Andy Kielbania for Expanded Role
2. Former NIH Chief Joins Children's National Medical Center
3. Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of Alex Leaf Distinguished Scientist Award
4. Crown Works Dental Laboratory hosts CE Course by Dr. Damon C. Adams, Editor -In -Chief of Dentistry Today
5. Resveratrol Supplement Company RevGenetics Welcomes New Chief Science Officer
6. iSirona Appoints Chief Quality and Regulatory Officer to Oversee Quality Initiatives
7. SafeShot Technologies Names Dr. Robert W. Beart as New Chief Executive Officer
8. Pollogen Ltd. Names Ohad Goren Chief Executive Officer
9. Consult A Doctor, Inc. Names Retail Clinic Pioneer, Douglas Smith, M.D. as Chief Medical Officer
10. HCMS Group LLC Names Mick Simon Chief Operating Officer
11. Cedars-Sinai Medical Center Names Beverly Hills Plastic Surgeon Dr. Andrew Cohen as Chief of the Center for Plastic and Reconstructive Surgery
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... 7th Annual 2015 Golden Bridge Business Awards under the New Products and Services ... capex web based sample management software that helps labs organize data ...
(Date:12/1/2015)... ... 01, 2015 , ... For many X-rays taken at hospitals, ... interpretation by the radiologist. The marking utensils are so small, however, they are ... a way to alleviate this problem. , He developed the patent-pending MARK N ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, ... been awarded a fixed price per sprint agile development contract to support the ... million over five years, provides software engineering, infrastructure, as well as operations and ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech North ... Gary has spent a significant amount of time in Sweden since joining PartnerTech ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani ... Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled ... Contact Center solutions targeted to the high-end enterprise contact center marketplace. , Ed ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Breg, Inc ., a ... today that it has been awarded three contracts by ... by Novation will have access to improved pricing for ... and soft goods dedicated to advancing orthopedic care.  ... aging U.S. population, rising prevalence of chronic conditions and ...
(Date:12/1/2015)... N.J. , Dec. 1, 2015 ... against HIV/AIDS, Johnson & Johnson (NYSE: JNJ ... its Janssen Pharmaceutical Companies to significantly reduce the ... who make up 74 percent of new HIV ... Announced on World AIDS Day, these new initiatives ...
(Date:12/1/2015)... 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a ... pain, announced today that the company will present at the ... 1-3 at the Luxe Sunset Boulevard Hotel in ... of Relmada Therapeutics, will present on Thursday, December 3, at ... . Please register at least 10 minutes prior to ...
Breaking Medicine Technology: